Work

Supplementary Figures 1 - 3, Table 1 from Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 5154KB, Table S1. Fedra'nib EC50 in the cHL and MLBCL cell lines. Figure S1. Immunohistochemical signature of chemical JAK2 inhibition in cHL and MLBCL cell lines. Figure S2. Transcript abundance of PIM1 in cHL and MLBCL cell lines. Figure S3. Tolerability study of fedra?nib in NSG mice.

DOI: 10.1158/1078-0432.22449981

Authors: Yansheng Hao, Bjoern Chapuy, Stefano Monti, Heather H. Sun, Scott J. Rodig, Margaret A. Shipp

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361908329

Cites:

Cited by:

Related to: 10